Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Using index level provides a macro view of market direction, helping you balance stock-specific decisions with overall sentiment.
27,685 articlesIonis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
A notable stake increase in Shift4 Payments hints at growing conviction from Maestria Partners. This deep dive explai...
A major investment move puts Clearwater Analytics stock lands squarely in the spotlight. With 77% ARR growth and chat...
Learn a practical plan to grow a multi-zone rental portfolio without traveling. This guide covers financing strategie...
In just one year, Nebius Group has moved from curiosity to a marquee name in AI infrastructure. This piece unpacks wh...
CoreWeave stock is front and center as data-center demand rises. With a growing backlog and expanding capacity plans,...
Investors are closely watching rivian’s stock ahead major launch as the company advances the R2 SUV, a lower-priced m...
A wave of optimistic notes suggests Palantir stock will push toward higher ground this year, underpinned by AI-driven...
Delta leads in profitability amid a volatile fuel backdrop, while JetBlue shows resilience with a tighter balance she...
A harsh week for AI chips created real bargains. This article identifies three beaten-down chip stocks worth a closer...
When a board member sells 7,000 shares, traders and long-term investors want to know why. This article breaks down Fo...
When volatility rattles the market, smart investors look for steady performers. Costco isn’t just a discount retailer...